Pronounced elongation of MEPs favours against the most common form of HSP, SPG4. As electrophysiological measures are independent of symptomatic treatment they might become important progression markers in upcoming HSP trials. The gene discussed is SPAST; the disease is hereditary spastic paraplegia.